Pfizer to slash 500 UK jobs in cost-cutting drive

15 November 2023
pfizer_black_new_large

Some 500 jobs are to go at US pharma giant Pfizer’s (NYSE: PFE) UK site in Sandwich, Kent.

This amounts to more than half of the 940 personnel employed at the Discovery Park facility, as the company closes its pharmaceutical sciences small molecule (PSSM) operations at the site.

Scientific and administrative positions will be cut, with reports claiming that these roles are likely to moved to other sites in India and the USA.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical